Novavax Reports Second Quarter 2018 Financial Results

Go back to Novavax Reports Second Quarter 2018 Financial Results

Novavax (NVAX) Reports In-Line Q2 EPS, Revenues Beat

August 8, 2018 4:56 PM EDT

Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $10.77 million versus the consensus estimate of $9.94 million.

In keeping with our stated 2018 objectives, Novavax reached two important milestones in the second quarter for our lead... More